Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) EBT (2020 - 2025)

Historic EBT for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$23.1 million.

  • Celularity's EBT fell 4334.7% to -$23.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.6 million, marking a year-over-year decrease of 13014.38%. This contributed to the annual value of -$57.9 million for FY2024, which is 7050.62% up from last year.
  • Celularity's EBT amounted to -$23.1 million in Q3 2025, which was down 4334.7% from -$24.5 million recorded in Q2 2025.
  • Celularity's EBT's 5-year high stood at $49.9 million during Q3 2021, with a 5-year trough of -$93.9 million in Q3 2023.
  • Its 5-year average for EBT is -$21.4 million, with a median of -$19.8 million in 2025.
  • Its EBT has fluctuated over the past 5 years, first skyrocketed by 70813.43% in 2022, then plummeted by 206311.17% in 2023.
  • Celularity's EBT (Quarter) stood at -$4.0 million in 2021, then skyrocketed by 708.13% to $24.4 million in 2022, then tumbled by 60.91% to $9.6 million in 2023, then plummeted by 239.09% to -$13.3 million in 2024, then plummeted by 73.6% to -$23.1 million in 2025.
  • Its EBT stands at -$23.1 million for Q3 2025, versus -$24.5 million for Q2 2025 and -$19.8 million for Q1 2025.